Abstract 93P
Background
Immune system plays an important role in the development, treatment response, and progression of triple-negative breast cancer. Here, we aimed to assess the dynamics of cell populations and their transcriptome changes during neoadjuvant chemotherapy (NACT) in triple-negative breast cancer patients.
Methods
Mononuclear cells were purified from peripheral venous blood before NACT, after 3rd and 21st days of NACT using a ficoll density gradient. Total cell concentration and viability (Calcein/DRAQ7) were assessed by flow cytometry (Cytoflex, Beckman Coulter). Single cells were sequenced on a NextSeq 2000 (Illumina) using targeted panel Immune Response from Rhapsody Express (Becton Dickinson). Data were analyzed using Seurat and SingleR.
Results
According to single cell sequencing data we revealed 10 main populations of mononuclear leukocytes: В cells (CD79+), NK cells (KIR2DL+), classical (CD14+) and non-classical (CD16+) monocytes, Т-cytotoxic cells (CD8+), Т-helpers (CD4+), T-regs (FOXP3+), CD4 memory cells (CD4+, IL32+, KLRB+, RGS1+), CD8 naïve (CD8+, LEF1+, CCR7+, PIK3IP1+), CD4 naïve (CD4+, LEF1+, CCR7+, PIK3IP1+). 3 days after NACT overexpression of BAX, FOSb, JUN, CXCR4, CD69 genes were observed, that mediating apoptosis of CD4 memory/naïve and CD8 naïve lymphocytes, T regs and monocytes; chemotaxis and proliferation of NK and Т-cytotoxic lymphocytes. The population of blood monocytes was selectively depleted (up to 3%). 21 days after NACT overexpression of CCR2, S100A9, ITGAM, CXCL8, CCL4, CCL5 genes were observed, mediating migration of monocytes to tissue, chemotaxis of immune cells and inflammation. The population of monocytes increased by up to 20%.
Conclusions
Chemotherapy affects the quantitative and qualitative composition of mononuclear leukocytes and changes their transcriptomic profile towards proinflammatory activation. This study was funded by the Russian Science Foundation (grant #22-75-10128).
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Russian Science Foundation, no.22-75-10128.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
45P - Therapeutic potential of ISM8207: A novel QPCTL inhibitor, in triple-negative breast cancer and B-cell non-Hodgkin lymphoma
Presenter: Sujata Rao
Session: Poster session 09
46P - Effect of coadministration of antioxidant chlorophyllin with docetaxel on invasion and metastasis in triple-negative breast cancer in vivo/in vitro
Presenter: Ayse Burus
Session: Poster session 09
47P - An ozone delivery system by cisplatin prodrug self-assembling micelles combining microwave to sensitizing immune checkpoint inhibitor in triple-negative breast cancer
Presenter: Dan Zheng
Session: Poster session 09
48P - Non-steroid anti-inflammatory treatment enhances the efficacy of modulated electro hyperthermia on triple-negative breast cancer and melanoma cancer models in vivo
Presenter: Nino Giunashvili
Session: Poster session 09
49P - Circulating miRNA signatures to predict recurrence in patients with pathological complete response of triple-negative breast cancer
Presenter: Ana Julia de Freitas
Session: Poster session 09
50P - Application and mechanism of tarloxotinib in HER2-positive breast cancer
Presenter: Xinyi Shao
Session: Poster session 09
51P - Nanoengineered sonosensitive platelets for synergistically augmented sonodynamic breast tumour therapy by glutamine deprivation and cascading thrombosis
Presenter: Liqiang Zhou
Session: Poster session 09
53P - Treatment of cancer cells based on circulating tumor cell’s expression profile using off-label drugs
Presenter: Panagiotis Apostolou
Session: Poster session 09
54P - Enhanced oxidative phosphorylation of metastasis-initiating cells facilitates esophageal tumor cell seeding in lymph nodes
Presenter: Shanshan Li
Session: Poster session 09
55P - Transcriptional profiles of engineered T cells stimulated with different receptor structures and co-stimulatory domains
Presenter: Ungue Shin
Session: Poster session 09